MassMutual Small Cap Growth Eq R4 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MassMutual Small Cap Growth Equity Fund Class R4 MSERX
- NAV / 1-Day Return 8.99 / +1.35 %
- Total Assets 661.9M
-
Adj. Expense Ratio
1.300%
- Expense Ratio 1.330%
- Distribution Fee Level Below Average
- Share Class Type Retirement, Medium
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 76%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MSERX
Will MSERX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
MKS Inc | 2.07 | 15M | Technology |
Fixed Inc Clearing Corp.Repo | 1.89 | 14M | Cash and Equivalents |
SiTime Corp Ordinary Shares | 1.46 | 11M | Technology |
Modine Manufacturing Co | 1.32 | 10M | Consumer Cyclical |
Alignment Healthcare Inc | 1.31 | 10M | Healthcare |
ESCO Technologies Inc | 1.12 | 8M | Technology |
BrightSpring Health Services Inc | 1.07 | 8M | Healthcare |
Sanmina Corp | 1.05 | 8M | Technology |
Protagonist Therapeutics Inc | 1.05 | 8M | Healthcare |
Fabrinet | 1.01 | 7M | Technology |